1. AB0451 Incidence of opportunistic infections during rituximab, abatacept or tocilizumab treatments for rheumatoid arthritis in clinical practice. (12th June 2018) Authors: Leon, L.; Peñuelas, M.; Candel, F.J.; Freites, D.; Rodriguez, L.; Jover, J.A.; Abasolo, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗